Quantitative PCR (qPCR) Market is expected to reach US$ 4.82 billion by 2031

Reagents and Consumables Segment to Lead Quantitative PCR (qPCR) Market During 2023–2031

According to our new research study on “Quantitative PCR (qPCR) Market Forecast to 2031 – Global Analysis – by Type, Product, Application, End User, and Geography,” the market was valued at US$ 2.57 billion in 2023 and is projected to reach US$ 4.82 billion by 2031; it is expected to register a CAGR of 8.2% from 2023 to 2031. Quantitative PCR (qPCR) is also termed as real-time PCR, as it facilitates the monitoring of the progression of a reaction in real time. In traditional PCR, DNA is amplified via multiple cycles of three repeating steps: denaturation, annealing, and elongation. In addition to the common reagents, a fluorophore is added to the sample when performing qPCR, which enables the collection of data in real time as PCR progresses. Relative gene expression can be calculated with this data. qPCR is extensively used for diagnostic and research purposes. In diagnosis, it is used to detect the specific genes of pathogens difficult to culture and capable of amplifying a specific fragment of DNA. Thus, technological advancements in PCR technologies and the growing demand for qPCR in infectious disease diagnoses are among the key factors bolstering the quantitative PCR (qPCR) market growth. However, high costs associated with real-time PCR systems hinder market growth. The integration of artificial intelligence and data analysis is projected to bring new quantitative PCR (qPCR) market trends in the coming years.

Quantitative PCR (qPCR) Market Analysis Based on Segmental Evaluation:

Based on type, the market is segmented into one-step qPCR and two-step qPCR. The two-step qPCR segment held a significant quantitative PCR (qPCR) market share in 2023, and it is estimated to register a higher CAGR during 2023–2031. By using a two-tube workflow, two-step qPCR allows for the independent optimization of both the reverse transcription and qPCR phases, providing the highest level of flexibility, specificity, and efficiency. Two-step qPCR works best with procedures that analyze several targets in fewer samples. The process of producing cDNA in a separate tube from the qPCR reaction is a major benefit of the two-step process, further making it possible to bank cDNA stocks for future use.

quantitative PCR (qPCR) Market, by Region, 2023(%)

Source: The Insight Partners Analysis

By product, the market is categorized into reagents and consumables, instruments, and software and services. The reagents and consumables segment held a significant quantitative PCR (qPCR) market share in 2023 and is estimated to register the highest CAGR during the forecast period. Reagents and consumables are important elements of qPCR procedures. These components include buffers, probes, enzymes, dyes, vials, kits, and panels, among others. Also, there are various kits available for gene expression analysis, microRNA analysis, and others. The growing demand for the early detection of diseases, prevalent use of consumables and reagents, and increasing demand for PCRs for healthcare, research, and other purposes have significantly fueled the market growth of the qPCR reagents and consumables segment. The reagents and consumables market is characterized by the presence of a large number of manufacturers such as Thermo Fisher Scientific, Kaneka Eurogentec S.A., and QIAGEN. Moreover, product developments and frequent product launches are among the major factors contributing to the growth of the market for this segment. In October 2022, Standard BioTools Inc. launched the X9 Real-Time PCR System, an innovative high-capacity genomics instrument offering superior efficiency. With over 9,000 individual nanoliter-volume reactions in a single run, X9 offers high data output, ensuring efficient, comprehensive sample profiling with little operator involvement.

The scope of the quantitative PCR (qPCR) market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. Asia Pacific is likely to register the highest CAGR in the market from 2023 to 2031. The increasing foreign direct investments in APAC countries and streamlining government policies resulting in high investments in biotechnology fuel the growth of the market in the region. In addition, increasing cases of infectious and chronic diseases, and various favorable initiatives by government and non-government entities are projected to support the Asia Pacific quantitative PCR (qPCR) market growth during the forecast period. China and Japan are the major contributors to the market growth in Asia Pacific. Market growth in China can be ascribed to the burgeoning demand for high-quality healthcare products, surging prevalence of lifestyle diseases, development of diagnostics facilities and hospitals, and rise in the number of medical specialties in hospitals. As per the article titled “Rare Disease Day: Why China’s Rare Disease Burden Could be an Opportunity for Innovation,” published in February 2023, ~20 million Chinese people suffer from rare diseases. The qPCR technique has proven to be a valuable tool for the diagnosis of such rare conditions. According to the Global Cancer Observatory data, about 4.56 million cancer cases were reported in 2020 in the country. The increasing prevalence of cancer in the country also contributes to the expanding growth of the quantitative PCR (qPCR) market size in China.

Abbott Laboratories, Thermo Fisher Scientific Inc., Standard Biotools Inc., F. Hoffmann-la Roche Ltd, Qiagen, Lepu Medical Technology Beijing Co Ltd, Bio-rad Laboratories Inc., Takara Bio Inc., Agilent Technologies Inc., and Fujirebio are among the leading companies profiled in the quantitative PCR (qPCR) market report.

Based on type, the quantitative PCR (qPCR) market is bifurcated into one-step qPCR and two-step qPCR. In terms of product, the market is classified into reagents and consumables, instruments, and software and services. By application, the market is segmented into research, clinical, and forensics. Based on end user, the market is categorized into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, forensic laboratories, and clinical research organizations. Based on geography, the quantitative PCR (qPCR) market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America)

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com